John C. Thomas

Insider Reports History

Identity 1 identity field
Location
Raleigh, NC
SEC filing record 1 source field
Reporting-owner signature
/s/ Greg Duncan, Attorney-in-Fact
SEC evidence 1 source field
Transaction evidence
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John C. Thomas

Form 4 holding Former Director

ImmunityBio, Inc.

Security class
Common Stock
Shares / value
202,477
Estimated value
$1,016,435
Report date
23 Feb 2021
Price
$5.02
Ownership
Direct
Form 4 holding Former Director

ImmunityBio, Inc.

Security class
Common Stock
Shares / value
13,886
Estimated value
$69,708
Report date
31 Dec 2021
Price
$5.02
Ownership
Indirect

Insider Reports Filed by John C. Thomas

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .